DOAJ Open Access 2023

05 Approved biologics for SLE: which to try first and in which patients? – The case for belimumab

Ronald van Vollenhoven

DOI

Topik & Kata Kunci

Immunologic diseases. Allergy

Penulis (1)

Ronald van Vollenhoven

Format Sitasi

APA MLA BibTeX

Vollenhoven, R.v. (2023). 05 Approved biologics for SLE: which to try first and in which patients? – The case for belimumab. https://doi.org/10.1136/lupus-2023-la.5

Akses Cepat

PDF tidak tersedia langsung

doi.org/10.1136/lupus-2023-la.5

Informasi Jurnal

Tahun Terbit: 2023
Sumber Database: DOAJ
DOI: 10.1136/lupus-2023-la.5
Akses: Open Access ✓